Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Endocrine 1

Conditions

Prostatic Neoplasms 45Brain Neoplasms 28Carcinoma, Non-Small-Cell Lung 27Carcinoma, Hepatocellular 24Neoplasm Metastasis 23Lung Neoplasms 18Pancreatic Neoplasms 14Breast Neoplasms 12Carcinoma, Renal Cell 11Neoplasms 10Sarcoma 7Melanoma 7Liver Neoplasms 7Kidney Neoplasms 5Head and Neck Neoplasms 5Colorectal Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Spinal Cord Neoplasms 3Spinal Cord Compression 3Small Cell Lung Carcinoma 3Recurrence 3Neuroma, Acoustic 3Colonic Neoplasms 3Radiation Injuries 2Prostate Cancer Metastatic 2Prostate Adenocarcinoma 2Ovarian Neoplasms 2Neoplasms, Second Primary 2Klatskin Tumor 2Hematologic Neoplasms 2

Interventions

Magnetic Resonance Spectroscopy 6Radiotherapy 4Biopsy 4Radiotherapy, Intensity-Modulated 3Cisplatin 3Blood Specimen Collection 3Narrow Band Imaging 2Mohs Surgery 2Fluorouracil 2Esophagectomy 2pembrolizumab 1fluoromisonidazole 1dacomitinib 1bintrafusp alfa protein, human 1Vitamin D 1Surveys and Questionnaires 1Standard of Care 1Sentinel Lymph Node Biopsy 1Second Harmonic Generation Microscopy 1Risk Factors 1Ribavirin 1Radiosurgery 1Protons 1Proflavine 1Pressure 1Photochemotherapy 1Phlebotomy 1Paclitaxel 1Observation 1Nimorazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Carcinoma, Squamous Cell × Radiosurgery × Clear all
NCT02357992 2022-10-14

Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy

M.D. Anderson Cancer Center

Phase NA Completed
122 enrolled 10 charts
EndocrineThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡